GW25-e1139 Effects of Bushen Hemai Prescription for Senile ISH: a randomised, single-blind trial  by Lu, Feng et al.
included into the ﬁnal model of clearance rate between compartments. After invali-
dation, the parameter estimates of ﬁnal model were close to the parameter mean of
Bootstrap, and included in the 95% conﬁdence interval.
Conclusions: (1) Amlodipine can increased tacrolimus steady-state C/D and AUC0-12 h
of PTH patients signiﬁcantly. (2) CYP3A5*3 gene polymorphism and hematocrit are
key inﬂuence factors of tacrolimus clearance. Amlodipine is key inﬂuence factor of
tacrolimus clearance rate between compartments.
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Relationship between Nocturnal Blood Pressure and Left Ventricular
Hypertrophy in Hypertensive Patients
Xue Hao, Hao Xue, Guoshu Liu
Chinese People’s Liberation Army General Hospital
Objectives: Left ventricular hypertrophy (LVH) is the most common target organ
damage in hypertension. However, the association of LVH and circadian rhythm of
blood pressure (BP) is unknown. The objective of the present study was to explore the
relationship between circadian rhythm of BP and LVH using ambulatory blood
pressure monitoring (ABPM).
Methods: A total of 325 untreated hypertensive patients were recruited. The patients
were divided into two groups: hypertensive patients with LVH (n¼121) and without
LVH (n¼204). Twenty-four-hour ABPM was performed in all the patients to collect
the following parameters: 24-hour average systolic and diastolic pressure, daytime
average systolic and diastolic pressure, nocturnal average systolic and diastolic
pressure, and night to day BP ratio. The relationship between LVH and the various
ABPM parameters was analyzed.
Results: We found that the average nocturnal systolic blood pressure (SBP) in
hypertensive patients with LVH was higher than that in hypertensive patients without
LVH (14516.1 mmHg vs 13612. 7mmHg, P<0.05). The average night to day SBP
ratio in hypertensive patients with LVH was also higher than that in hypertensive
patients without LVH (0.930.04 vs 0.860.04, P<0.05). Multiple regression anal-
ysis indicate that the average nocturnal SBP and the night to day SBP ratio were
associated with LVH (Odds ratio (OR) 1.67, 95% CI 1.31-3.21; OR: 1.88, 95% CI
1.56-3.78) by adjustment for traditional covariates.
Conclusions: The average nocturnal SBP and the average night-day SBP ratio are
independent risk factors of LVH in patients with hypertension.
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Objectives: Catheter-based renal sympathetic denervation (RDN) was introduced as a
novel interventional technique in recent years, which could simultaneously block the
renal artery afferent and efferent nerve ﬁbers and showed remarkable therapeutic
effects in the treatment of resistant hypertension. In our study, we attempted to use the
QCA system to evaluate the changing about diameter of renal artery after the RDN
immediately.
Methods: 16 patients with resistant hypertension were enrolled and all of them were
accepted the RDN. We used the QCA system to evaluate the diameter of renal artery
before and after the RDN immediately (the renal artery diameter about 2-3 mm were
selected in each patient for measurement).
Results: All of the 16 patients were successfully completed the RDN. No stenosis was
observed in all renal arteries. The result showed that dilation of all patients’ renal
arteries could be observed, and compared with the diameter before RDN, there was
signiﬁcant difference (2.50.4 mm vs 3.10.5 mm, P<0.001, the changing rate
was 24%).
Conclusions: The renal sympathetic denervation could induce the dilation of renal
artery diameter immediately.
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Objectives: To investigate the association between plasma aldosterone (ALD) witn
KCNJ5 (rs2604204) gene polymorphisms in primary hypertension patients.
Methods: 229 new diagnosed primary hypertensive patients without any antihyper-
tensive agents had been selected from October 2011 to January 2014 in the hyper-
tension laboratory of Fujian provincial cardiovascular disease institute. Hypertension
patients were divided into two groups depended on the median of ALD (183.18 ng/l):
high ALD group (n¼114) and control group (n¼115). Clinical data, serum
biochemical, rennin-angiotensin-aldosterone, cortisol, ambulatory blood pressure and
echocardiography data were recorded. Polymerase chain reaction (PCR) was used to
characterize KCNJ5 (rs2604204) genotypes (A/C).JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CResults: (1) The frequency of different genotypes of KCNJ5 (rs2604204) were in
accordance with Hardy-Weinberg equilibrium in our study (P>0.05). (2) Clinical
characteristics:Compared with control group, the triglyceride (TG), uric acid (UA),
insulin, insulin resistance index, renin, angiotensin I, angiotensin II, cortisol, 24hSBP,
dSBP, SD (PD), SD (PS), left ventricular mass index (LVMI) were high in high ALD
group (P<0.05). The gender, age, height, weight, BMI, waist circumference, total
cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipopro-
tein cholesterol (HDL-C), fasting blood glucose (FBG), glycosylated hemoglobin A1c
(HbA1c), sodium, potassium, 24h DBP, dDBP, nSBP, nDBP showed no signiﬁcant
difference between two groups. (3) Gene polymorphisms: Compared with control
group, the distribution frequency of AC and CC genotypes of KCNJ5 gene were more
in high ALD group (x2¼10.93,P¼0.004),and C allelic frequency was also more in
high ALD group (x2¼9.78, P¼0.002). There was no signiﬁcant difference between
AC and CC genotypes of two groups. Compared with hypertensive patients with AA
genotype, patients with C allelic showed increased high ALD risk (x2¼9.808,
OR¼2.36 95% CI 1.380-4.049, P¼0.002). (4) Analysis of the risk factors of high
ALD: After adjusting the TG, UA, cortisol, insulin, insulin resistance index, renin,
angiotensin I, angiotensin II, cortisol, 24h SBP, dSBP, SD (PD), SD (PS), LVMI,
logistic regression analysis showed that KCNJ5 genotype, angiotensin II, cortisol,
dSBP entered into the regression equation, compared with hypertensive patients with
AA genotype, hypertensive patients with C allelic showed increased high ALD risk
(OR¼2.33, 95% CI 1.255-4.353, P¼0.007).
Conclusions: The KCNJ5 (rs2604204) gene C allelic might be a susceptibility factor
to the high ALD in primary hypertensive patients. Angiotensin II, cortisol, dSBP are
related to the high ALD in primary hypertensive patients.
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Objectives: To evaluate the curative effect of Bushen Hemai Prescription combined
with antihypertensive chemical medicine on the control rate of systolic blood pressure
(SBP), pulse pressure (PP) and left ventricular hypertrophy (LVH) in senile isolated
systolic hypertension (ISH) patients.
Methods: It was designed as multi-center clinical research (5 medical centers) of
completely randomized, single blind and parallel blank control. After 2 weeks of
introduction period, 286 cases of aged over 60 years, with more than 15-20 years
duration and PP 60 mmHg (8 kPa) were enrolled and were divided into the control
group (n¼144) and the experimental group (n¼142). During the observation period of
24 weeks, patients were allocated with chemical medicine (Amlodipine + Indapamide)
and combination therapeutic regimen (Bushen Hemai Prescription combined with
Amlodipine + Indapamide). 24 h ambulatory blood pressure parameters were monitored
according to the British Oxford Medliog ambulatory blood pressure analysis system.
Left ventricular end diastolic diameter (LVEDd), interventricular septal thickness
(IVSTDd) and left ventricular posterior wall thickness (PWTDd) of 3-5 continuous
heartbeat cycle were determined by GEVivid 7 PRO color Doppler ultrasound diag-
nostic instrument. Left ventricular mass (LVM), left ventricular mass index (LVMI) and
relative wall thickness (RWT) were calculated according to the Devercux formula.
Results: After therapy, analysis of the control rate of SBP and PP was 45.14%
(control group) and 74.32% (experimental group) by chi square test of FAS analysis,
P<0.01, and 48% (control group) and 74.96% (experimental group) by chi square test
of PPS analysis, P<0.01. The efﬁciency analysis of circadian rhythms was 25.93%
(control group) and 47.06% (experimental group) by chi square test of FAS analysis,
P<0.01, and 25% (control group) and 46.39% (experimental group) by chi square test
of PPS analysis, P<0.01. Ultrasonic Beckoning graph showed that data about LVH
were decreased in both two groups after treatment. LVM and LVMI were decreased
signiﬁcantly in experimental group than in control group (P<0.01), suggesting cardiac
diastolic function was improved more signiﬁcantly. There is no central difference of
each data among the 5 medical centers by Breslow-Day test, P>0.05.
In the process of study, the incidence of adverse events was 2.08% (A group) and
0% (B group), demonstrating no statistically signiﬁcance difference between groups
by corrected chi square test, P>0.05. And none was serious adverse event.
Conclusions: Combination therapeutic regimen (Bushen Hemai Prescription com-
bined with Amlodipine + Indapamide) could more effectively control 24h blood
pressure, improve the control rate of systolic blood pressure (SBP), pulse pressure
(PP) and improve left ventricular diastolic function, reverse concentric LVH in senile
isolated systolic hypertension (ISH) patients. This combination therapeutic regimen
may bring a greater long-term beneﬁt to senile ISH patients.
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Objectives: Renal denervation (RDN) emerges as a potential adjunct in the treatment
of resistant hypertension (RH) with limited data. We aim to evaluate the efﬁcacy of
RDN mainly by ambulatory blood pressure monitoring (ABPM).ardiovascular Disease Clinical Research C177
